These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 3607369)
21. Role of the endocardium in the inotropic action of UD-CG-212 CL. Meulemans AL; Brutsaert DL Eur J Pharmacol; 1991 Sep; 202(1):45-9. PubMed ID: 1686255 [TBL] [Abstract][Full Text] [Related]
22. Acute hemodynamic effects of nisoldipine and pimobendan in conscious pigs with chronic heart failure. van der Giessen WJ; van Woerkens LJ; Duncker DJ; Roelandt JR; Verdouw PD J Cardiovasc Pharmacol; 1989 Oct; 14(4):653-8. PubMed ID: 2478781 [TBL] [Abstract][Full Text] [Related]
23. Hemodynamic effects of intravenous pimobendan in patients with left ventricular dysfunction. Remme WJ; Wiesfeld AC; Look MP; Kruyssen HA J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S41-4. PubMed ID: 2478791 [TBL] [Abstract][Full Text] [Related]
24. Usefulness of pimobendan in the treatment of heart failure. Duncker DJ; van Dalen FJ; Hartog JM; Lamers JM; Rensen RJ; Saxena PR; Verdouw PD Arzneimittelforschung; 1986 Dec; 36(12):1740-4. PubMed ID: 3032212 [TBL] [Abstract][Full Text] [Related]
25. Reversal of phosphate induced decreases in force by the benzimidazole pyridazinone, UD-CG 212 CL, in myofilaments from human ventricle. Fraker LD; Van Eyk J; Solaro RJ Mol Cell Biochem; 1997 Nov; 176(1-2):83-8. PubMed ID: 9406148 [TBL] [Abstract][Full Text] [Related]
26. Effects of pimobendan and its active metabolite, UD-CG 212 Cl, on Ca2+-activated K+ channels in vascular smooth-muscle cells. Chen CH; Nakaya Y; Minami K; Kubo M J Cardiovasc Pharmacol; 1997 Dec; 30(6):739-43. PubMed ID: 9436812 [TBL] [Abstract][Full Text] [Related]
27. Differential cardiovascular and neuroendocrine effects of epinine and dopamine in conscious pigs before and after adrenoceptor blockade. van Woerkens LJ; Boomsma F; Man in 't Veld AJ; Bevers MM; Verdouw PD Br J Pharmacol; 1992 Oct; 107(2):303-10. PubMed ID: 1330172 [TBL] [Abstract][Full Text] [Related]
28. Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction. Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR J Cardiovasc Pharmacol; 1988; 12(5):547-54. PubMed ID: 2468054 [TBL] [Abstract][Full Text] [Related]
29. Systemic haemodynamic and beta-adrenoceptor antagonistic effects of bisoprolol in conscious pigs: a comparison with propranolol. Duncker DJ; Saxena PR; Verdouw PD Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):54-63. PubMed ID: 2895611 [TBL] [Abstract][Full Text] [Related]
30. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy]. Permanetter B; Sebening H; Busch U; Lutilsky L Z Kardiol; 1990 Aug; 79(8):565-72. PubMed ID: 2220013 [TBL] [Abstract][Full Text] [Related]
31. UD-CG 115--a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle. Honerjäger P; Heiss A; Schäfer-Korting M; Schönsteiner G; Reiter M Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):259-69. PubMed ID: 6328334 [TBL] [Abstract][Full Text] [Related]
32. Correlations between the cardiovascular effects of pimobendan and plasma concentrations of the parent compound and of its major active metabolite, UD-CG 212 CL, in patients with congestive heart failure. Hagemeijer F; Roth W; Brand HJ J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S57-64. PubMed ID: 2478794 [TBL] [Abstract][Full Text] [Related]
33. Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties. Narimatsu A; Kitada Y; Satoh N; Suzuki R; Okushima H Arzneimittelforschung; 1987 Apr; 37(4):398-406. PubMed ID: 3606694 [TBL] [Abstract][Full Text] [Related]
34. Cardiovascular effects and plasma levels of denopamine (TA-064), a new positive inotropic agent, in chronically instrumented dogs. Ikeo T; Nagao T; Suzuki T; Yabana H; Nakajima H Jpn J Pharmacol; 1985 Oct; 39(2):191-9. PubMed ID: 4087566 [TBL] [Abstract][Full Text] [Related]
35. Effects of pimobendan, its active metabolite UD-CG 212, and milrinone on isolated blood vessels. Fujimoto S Eur J Pharmacol; 1994 Nov; 265(3):159-66. PubMed ID: 7875231 [TBL] [Abstract][Full Text] [Related]
36. Effects of pimobendan and UD-CG-212 CL on calcium exchange and contraction in isolated rabbit aorta. Tejerina T; Sesin J; Delgado C; Gonzalez P; Tamargo J Arch Int Pharmacodyn Ther; 1990; 305():69-85. PubMed ID: 2241431 [TBL] [Abstract][Full Text] [Related]
37. Systemic haemodynamics of dihydropyridine derivatives in conscious pigs with or without propranolol. Duncker DJ; Saxena PR; Verdouw PD Eur J Pharmacol; 1988 Nov; 156(3):401-9. PubMed ID: 3215283 [TBL] [Abstract][Full Text] [Related]
38. Cardiovascular pharmacology of RS-1893, an orally active cardiotonic agent with arterial and venous vasodilator actions. Miyake S; Shiga H; Koike H; Mizuno H; Yorikane R; Oda T; Iijima Y; Kumakura S; Morisawa Y Jpn J Pharmacol; 1988 Jul; 47(3):273-83. PubMed ID: 2851676 [TBL] [Abstract][Full Text] [Related]
39. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril. Hauf GF; Grom E; Jähnchen E; Roskamm H J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S49-56. PubMed ID: 2478793 [TBL] [Abstract][Full Text] [Related]
40. 5-Hydroxytryptamine-induced increase in left ventricular dP/dtmax does not suggest the presence of ventricular 5-HT4 receptors in the pig. Saxena PR; Villalón CM; Dhasmana KM; Verdouw PD Naunyn Schmiedebergs Arch Pharmacol; 1992 Dec; 346(6):629-36. PubMed ID: 1484564 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]